Source: Eur Respir Rev 2013; 22: 37-43
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Philip Tønnesen. Smoking cessation and COPD. Eur Respir Rev 2013; 22: 37-43

Member's Comments

No comment yet.

Related content which might interest you: Smoking cessation and prevention Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242 Year: 2006 Smoking cessation strategies in patients with COPD Source: Eur Respir J 2013; 41: 727-734 Year: 2013 COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Recommendations for smoking cessation treatment in respiratory patients Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 Introductory lecture: Nicotine addiction treatment in COPD patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006 Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Smoking cessation in patients with respiratory diseases Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Effectiveness of a smoking cessation programme for COPD (SMOCC) in routine general practice Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 The SMOKE study: 1 year evaluation of an intensive multi-component smoking cessation programme for COPD outpatients Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 Efficacy of confronting smokers with airflow limitation for smoking cessation Source: Eur Respir J 2009; 33: 754-762 Year: 2009 Varenicline for smoking cessation in a rehabilitation center for pulmonary diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008 Pharmacological treatment for smoking cessation Source: Eur Respir Mon; 2008: 42: 74–97 Year: 2008 Evidence for harm reduction in diseased smokers Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited Year: 2007 Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008 The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018 Success of smoking cessation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005